Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BMY
Stock Latest News
Ratings
Hold Rating Maintained for Bristol-Myers Squibb Amid Uncertainty in CELMoD Franchise Developments
12h ago
BMY
Premium
The Fly
Bristol Myers’ iberdomide shows improvement in Phase 3 myeloma study
17h ago
BMY
Premium
The Fly
Bristol Myers commitment a reminder of Veeva’s progress, says Stifel
1d ago
BMY
GSK
Premium
The Fly
Veeva says Bristol Myers commits to Veeva Vault CRM
2d ago
BMY
VEEV
Premium
Ratings
Bristol-Myers Squibb: Hold Rating Amid Slower Cobenfy Launch and Fair Valuation
9d ago
BMY
Premium
The Fly
Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
11d ago
DV
ES
Premium
The Fly
Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads
13d ago
DV
AZN
Premium
The Fly
Omnicom, WPP under pressure after Trump moves to regulate pharma ads
14d ago
AZN
BMY
Premium
The Fly
Trump Trade: U.S. President signs new pharma order
14d ago
DV
AZN
Premium
The Fly
Trump signs memorandum mandating pharma ads give more info on risks
14d ago
AZN
BMY
Premium
Ratings
Cautious Optimism for Bristol-Myers Squibb Amid Promising Data and Ongoing Concerns
15d ago
BMY
Premium
The Fly
Truist says BioNTech posts wins in small cell lung cancer, ‘327 in pole position
15d ago
BMY
BNTX
Premium
The Fly
BioNTech, Bristol Myers present interim data from a Phase 2 pumitamig trial
16d ago
BMY
BNTX
Premium
Ratings
Hold Recommendation for Bristol-Myers Squibb Due to Cobenfy’s Modest Growth and Revenue Projections
16d ago
BMY
Premium
The Fly
Private Markets: Anthropic raises $13B Series F at $183B post-money valuation
19d ago
AI
GS
Premium
The Fly
Cytokinetics price target raised to $80 from $60 at Evercore ISI
21d ago
BMY
CYTK
Premium
Market News
REPL Lawsuit Alert! Class Action Lawsuit Against Replimune Group
21d ago
BMY
REPL
Premium
The Fly
Cytokinetics price target raised to $96 from $87 at Stifel
22d ago
BMY
CYTK
Premium
Ratings
Cautious Hold Rating on Camzyos Amid Evolving Cardiac Myosin Inhibitor Landscape
22d ago
BMY
Premium
The Fly
Bristol Myers presents results from COLLIGO-HCM trial at ESC Congress
26d ago
BMY
Premium
Ratings
Hold Rating for Bristol-Myers Squibb Amid Uncertain Revenue Projections and Fair Valuation
30d ago
BMY
Premium
Company Announcements
Bristol-Myers Squibb’s Promising Phase 3 Study on KarXT for Bipolar-I Disorder
1M ago
BMY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
